Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - LekS.A.
Manufacture of pharmaceutical preparations
Overview
Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - is a Polish manufacturer of pharmaceuticals, dietary supplements, and products for both pharmacy and non-pharmacy markets. Their brands include IBUM, DIH, Ulgix, and NaturKaps, and they have been committed to high-quality pharmaceutical products since the 1980s.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
HASCO Group Publishes First 2025 Sustainability Report
ESG Program in the Hasco Group
Together We Greened Hasco-Lek Offices
Hasco-Lek in Key Debates on Poland's Economic Future and Drug Security
Over 2800 tests and consultations. What the nationwide campaign “Gentlemen! Ride for health” revealed about men's health
Announcement regarding the withdrawal of the medicinal product series Thyme Compound Syrup Herbal Tradition
Industry
Bank accounts
Registered as a VAT taxpayer on 2005-11-01. Active
16 1020 5226 0000 6502 0605 0308
24 1160 2202 0000 0005 9340 0394- 50 1160 2202 0000 0006 1080 1047
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $2.1M$2,079,872 |
Buildings and premises | $27.0M$26,970,192 |
Public aid
21 public aid cases recorded, with a total value of $4,834,430.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 7, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Agencja Rozwoju Regionalnego Arleg S.A. | |
| Nov 28, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezydent Wrocławia | |
| Nov 25, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Dolnośląska Agencja Rozwoju Regionalnego S.A. |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2017-10-01 | Wdrożenie innowacji procesowej w Przedsiębiorstwie Produkcji Farmaceutycznej Hasco-Lek S.A. w postaci wspomagania komputerowego interpretacji danych analitycznych i procesowych w celu definiowana przestrzeni projektowej w toku prac B+R nad nowymi produktami poprzez zakup specjalistycznej aparatury i oprogramowania | $282.8K$282,774 | Regionalny Program Operacyjny Województwa Dolnośląskiego 2014-2020 |
Tenders
No recorded participation in tenders.
Trademarks
Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - Lek currently holds no active trademarks with the Polish Patent Office. 44 marks have expired or were not registered. The first mark was filed in 1995.
| Mark | Protected until | |
|---|---|---|
| Hascoderm lipocontrol(word) | – | |
| Mark without a word element(figurative) | – | |
| LORAST(word) | – | |
| Ulgix regulacja | – | |
| BluMAG jedyny | – |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | Waste generation | Active |
Authorized Representatives
Manner of representation
For submitting declarations of will on behalf of the company and signing documents, each member of the management board is authorized to act independently.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Medico - Investmentsp. z o.o. | 16,484,486.76 USD | 84.6184% | ||
Haston City Hotelsp. z o.o. | 3,510,399.78 USD | 99.9654% | ||
Recepto Pharmasp. z o.o. | 332,793.08 USD | 72.0468% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Aflofarm Farmacja Polskasp. z o.o. | $302,019,142.07 | aflofarm.pl | ||
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $160,174,284.28 | anpharm.pl | ||
| Biofarmsp. z o.o. | $143,422,260.45 | biofarm.pl | ||
| Sciencepharmasp. z o.o. | $111,783,976.52 | sciencepharma.com | ||
| Delpharm PoznańS.A. | $110,900,246.81 | delpharm.com | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| ICN Polfa RzeszówS.A. | $85,044,250.03 | icnpolfa.pl | ||
| Synoptis Pharmasp. z o.o. | $79,311,000.88 | synoptispharma.pl | ||
| PolfarmexS.A. | $73,543,379.32 | polfarmex.pl | ||
| Wrocławskie Zakłady Zielarskie HerbapolS.A. | $46,537,868.51 | herbapol.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-10-08 | PKD change (Removed: 10.89.Z, 72.11.Z, 72.19.Z; Added: 10.86.Z, 10.89.A, 72.10.Z) | |
| 2004-03-30 | Share capital change (10,000,000.00 PLN → 329,944,036.00 PLN) | |
| 2003-10-28 | Name change ("hasco-Investment" → "przedsiębiorstwo Produkcji Farmaceutycznej Hasco - Lek") | |
| 2002-05-14 | Share capital change (1,500,000.00 PLN → 10,000,000.00 PLN) | |
| 2001-09-21 | Address change (Olsztyńska 5, 51-423, Wrocław → Żmigrodzka 242e, 51-131, Wrocław) |
FAQ
Last updated: 2026-10-08